To compare amh levels between women receiving intra ovarian platelet rich plasma injection to those receiving intra ovarian saline injection in women with infertility due to primary ovarian failure

Comparison of the effect of intra ovarian platelet rich plasma injection to intra ovarian saline injection in women with poor ovarian reserve: an open labelled randomised controlled trial - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069310

Enrollment

Registered

2024-06-20

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: X- New Technology

Interventions

Intervention1: autologous platelet rich plasma: patients blood will be used to create autologous platelet rich plasma It will be injected once intraovarian during laparoscopy It will be followed up w

Eligibility

Inclusion criteria

Inclusion criteria: anti mullerian hormone less than 1.1ng/dl patient willing to undergo laparoscopy hysteroscopy fertility enhancing surgery and willing to consent

Exclusion criteria

Exclusion criteria: active pelvic inflammatory disease abnormal ovary on USG known platelet or thromboxane synthesis disorder/abnormal coagulation profile

Design outcomes

Primary

Measure	Time frame
improved ovarian parameters increase in anti mullerian hormone, Antral follice count decrease in FSH after 12 weeksTimepoint: improved ovarian parameters increase in anti mullerian hormone, Antral follice count decrease in FSH after 3 months(12weeks)	—

Secondary

Measure	Time frame
biochemical/clinical pregnancy rateTimepoint: 1 year	—

Countries

India

Contacts

Public ContactPuja Vidushi

AIIMS patna

Vidushijvm.19@gmail.com8368047717

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026